Next Article in Journal
Comorbidities and Quality of Life among Breast Cancer Survivors: A Prospective Study
Previous Article in Journal
Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling?
Article Menu

Export Article

Open AccessReview
J. Pers. Med. 2015, 5(2), 213-228; doi:10.3390/jpm5020213

Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe

1
Phamax Analytics Resources Pvt. Ltd. #19, KMJ Ascend 1st Cross, 17th C Main 5th Block, Koramangala Bangalore 560 095, India
2
Unicorn, POB 91, Zhytomyr 10020, Ukraine
*
Author to whom correspondence should be addressed.
Academic Editor: Stephen B. Liggett
Received: 27 March 2015 / Revised: 25 May 2015 / Accepted: 26 May 2015 / Published: 12 June 2015
View Full-Text   |   Download PDF [816 KB, uploaded 12 June 2015]   |  

Abstract

The pharma ecosphere is witnessing a measured transformation from the one-size-fits-all or blockbuster model of drugs to more informed and tailored personalized treatments that facilitate higher safety and efficacy for a relevant sub-population. However, with several breakthroughs still in a nascent stage, market access becomes a crucial factor for commercial success, especially when it comes to co-creating value for pertinent stakeholders. This article highlights diverse issues from stakeholder perspectives in Europe, specifically the ones which require immediate resolution. Furthermore, the article also discusses case studies articulating potential solutions for the issues discussed. View Full-Text
Keywords: Stratified medicine; companion diagnostics; market access; cost-effectiveness; value addition Stratified medicine; companion diagnostics; market access; cost-effectiveness; value addition
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Akhmetov, I.; Ramaswamy, R.; Akhmetov, I.; Thimmaraju, P.K. Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe. J. Pers. Med. 2015, 5, 213-228.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top